Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial

BACKGROUND: Optimal antimicrobial drug exposure in the lung is required for successful treatment outcomes for nosocomial pneumonia. Little is known about the intrapulmonary pharmacokinetics (PK) of meropenem when administered by continuous infusion (CI). The aim of this study was to evaluate the PK...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Crit Care
Autori principali: Benítez-Cano, Adela, Luque, Sonia, Sorlí, Luisa, Carazo, Jesús, Ramos, Isabel, Campillo, Nuria, Curull, Víctor, Sánchez-Font, Albert, Vilaplana, Carles, Horcajada, Juan P., Adalia, Ramón, Bermejo, Silvia, Samsó, Enric, Hope, William, Grau, Santiago
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2020
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7026992/
https://ncbi.nlm.nih.gov/pubmed/32066497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-020-2763-4
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi